Viscoelasticity and the Small Punch Creep Recovery Test: Numerical analysis and experimental tests on the applicability for polyvinyl chloride (PVC)

Research on the Small Punch Test (SPT) has been mainly focused on metallic alloys, with limited investigations in polymeric materials. The miniature size of the SPT eases and motivates its use in biomedical applications, like the mechanical characterization of surgical implants made of different polymers. It is noted that the aim of these publications was focused on mechanical properties inherent to the tensile test (yield strength, ultimate tensile strength, Young's modulus, etc.), but the applicability of this miniature test for the estimation of singular polymer properties like viscoelasticity or viscoplasticity has not been addressed. The aim of this paper was the assessment of SPT as a characterization test for the viscoelastic properties of polymers. To analyze this applicability, numerical FEM simulations of hypothetical materials were performed and a novel Small Punch Creep Recovery Test (SPCRT) was designed. These FEM simulations were verified with experimental compressive creep recovery tests and SPCRTs for specimens made of polyvinyl chloride (PVC). The results showed that SPCRTs accurately estimated the viscoelastic properties for materials with non-stress-dependent viscoelastic properties. In the case of materials with stress-dependent viscoelastic properties, the SPCRT would estimate a mean or intermediate value of these stress-dependent viscoelastic properties

Implementation of the GTN Damage Model to Simulate the Small Punch Test on Pre-Cracked Specimens

11th International Conference on the Mechanical Behavior of Materials (ICM11), Como (Italy), 2011Nowadays, pre-cracked Small Punch Tests (P-SPT) are used in those cases where there is not enough material for conducting conventional tests. In this paper, P-SPT has been used to determine the fracture properties of the 15.5PH steel, using the micromechanical model, developed by Gurson-Tvergaard-Needleman (GTN). The effect of variation of damage parameters on the numerical simulation has been analyzed. This numerical simulation is based on the sequential adjustment of the experimental load-displacement curves obtained from P-SPT. Interrupted test have been also developed in order to know the cracking process during loading and the damage evolution until fracture.Project MCI Ref: MAT2008-06879-C03-03/MA

Ring Hoop Tension Test for yield strength estimation: Numerical analysis for a novel correlation method and applicability for mechanical testing of tubes and pipes

The tubes and pipes manufacturing industry characterizes the mechanical properties of their products with a wide selection of standards, but most of them are qualitative testing methodologies. To estimate the mechanical properties from a quantitative point of view there are limited options in standards. In that sense, the standard tensile test is the preferred alternative by the manufacturers, but this option limits the mechanical estimation for the longitudinal direction of the tube–pipe product. Particular efforts have been made to design an alternative mechanical testing procedure to characterize the mechanical properties in the hoop direction of pipes and tubes. The Ring Hoop Tension Test (RHTT) was designed to fill this gap, but it shows limitations related to the required tooling and the influence of the frictional contact between the tooling and the ring specimen. In the nuclear industry, the Small Ring Test (SRT), a miniature test derivated from the RHTT, has been investigated in recent years. In this investigation, a novel RHTT was designed to overcome the limitations of SRT and RHTT, and a new procedure was implemented to estimate the yield strength of tubes and pipes. Numerical FEM simulations were performed to reach an optimum estimation method for the yield strength with the specific geometry of the SRT and a wide selection of pipe geometries with the RHTT. A set of hypothetical materials were designed to perform these analyses, taking into account the influence of Young’s modulus, proportional limit, hardening coefficient (based on the Ramberg–Osgood law), and presence of Lüders bands straining. To verify the results obtained from this numerical FEM analysis, experimental tests (standard tensile tests and RHTTs) and metallographic analysis were performed on aluminum Al 6063 T6 and copper C12200 R360 tubes, showing the capability of this optimized RHTT to estimate the yield strength in the hoop direction for anisotropic tubes and pipes

Application of the Small Punch Creep-Recovery Test (SPCRT) for the Estimation of Large-Amplitude Viscoelastic Properties of Polymers

The Small Punch Creep-Recovery Test (SPCRT) is a novel miniature test used to estimate the viscoelastic properties of polymers and biomaterials. The current investigation related to the SPCRT is limited to Finite Element Method (FEM) simulations and experimental tests on PVC. The aim of this investigation was focused on: (i) extending the experimental tests to other polymers with dissimilar viscoelastic properties; (ii) deepening the influence of non-linear viscoelastic properties in the estimation capabilities of the SPCRT; and (iii) developing a numerical methodology to estimate and take into account the viscoelastic recovery produced during the unloading step of compressive creep-recovery tests (CCRT) and SPCRTs. The experimental tests (CCRTs and SPCRTs) were done on polyethylene PE 500, polyoxymethylene POM C, nylon PA 6, and polytetrafluoroethylene (PTFE), with a range of creep loads, in the case of CCRTs, in the whole elastic regime and the surroundings of the yield strength of each material. The experimental results confirmed that the SPCRT was an accurate and reliable testing method for linear viscoelastic polymers. For a non-linear viscoelastic behavior, SPCRT estimated the viscoelastic properties obtained from CCRTs for creep loads near the yield strength of the polymer, which corresponded with large-amplitude viscoelastic properties in dynamic creep testing. In order to consider the viscoelastic recovery generated in the unloading step of CCRTs and SPCRTs, a Maxwell-Wiechert model with two branches was used, simulating the different steps of the experimental tests, and solving numerically the differential equation of the Maxwell-Wiechert model with the Runge-Kutta-Fehlberg (RKF) numerical method. The coefficients of the elements of the Maxwell-Wiechert model were estimated approaching the straining curve of the recovery step of the simulation with the same curve registered on each experimental test. Experimental CCRTs with different unloading times demonstrated that the use of this procedure derived in no influence of the unloading step time in the viscoelastic properties estimation

A new prediction method for the ultimate tensile strength of steel alloys with small punch test

The load–deflection curve acquired from the Small Punch Test (SPT) is used to obtain the mechanical properties of materials using different correlation methods. The scattering level of these regressions tends to be high when a wide set of materials is analyzed. In this study, a correlation method based on a specific slope of the SPT curve was proposed to reduce scattering. Assuming the Ramberg–Osgood hardening law, the dependence of the SPT curve slope on the yield strength and the hardening coefficient is demonstrated by numerical simulations (FEM). Considering that the ultimate tensile strength could be obtained from the hardening coefficient, a response surface of the ultimate tensile strength with the yield strength and SPT curve slope, along with its equation, is presented for steel alloys. A summary of steel mechanical properties, based on the Boiler and Pressure Vessel Code (BPVC) and limited to yield strengths lower than 1300 MPa, is shown to select a set of experimental tests (tensile tests and SPTs) for which the range is completely covered. This experimental analysis validates the previous FEM analyses and the validity of the proposed correlation method, which shows more accurate correlations compared to the current method

Genetic Study of SARS-CoV-2 Non Structural Protein 12 in COVID-19 Patients Non Responders to Remdesivir

Remdesivir (RDV) was the first antiviral drug approved by the FDA to treat severe coronavirus disease-2019 (COVID-19) patients. RDV inhibits SARS-CoV-2 replication by stalling the non structural protein 12 (nsp12) subunit of the RNA-dependent RNA polymerase (RdRp). No evidence of global widespread RDV-resistance mutations has been reported, however, defining genetic pathways to RDV resistance and determining emergent mutations prior and subsequent antiviral therapy in clinical settings is necessary. This study identified 57/149 (38.3%) patients who did not respond to one course (5-days) (n = 36/111, 32.4%) or prolonged (5 to 20 days) (n = 21/38, 55.3%) RDV therapy by subgenomic RNA detection. Genetic variants in the nsp12 gene were detected in 29/49 (59.2%) non responder patients by Illumina sequencing, including the de novo E83D mutation that emerged in an immunosuppressed patient after receiving 10 + 8 days of RDV, and the L838I detected at baseline and/or after prolonged RDV treatment in 9/49 (18.4%) non responder subjects. Although 3D protein modeling predicted no interference with RDV, the amino acid substitutions detected in the nsp12 involved changes on the electrostatic outer surface and in secondary structures that may alter antiviral response. It is important for health surveillance to study potential mutations associated with drug resistance as well as the benefit of RDV retreatment, especially in immunosuppressed patients and in those with persistent replication. IMPORTANCE This study provides clinical and microbiologic data of an extended population of hospitalized patients for COVID-19 pneumonia who experienced treatment failure, detected by the presence of subgenomic RNA (sgRNA). The genetic variants found in the nsp12 pharmacological target of RDV bring into focus the importance of monitoring emergent mutations, one of the objectives of the World Health Organization (WHO) for health surveillance. These mutations become even more crucial as RDV keeps being prescribed and new molecules are being repurposed for the treatment of COVID-19. The present article offers new perspectives for the clinical management of non responder patients treated and retreated with RDV and emphasizes the need of further research of the benefit of combinatorial therapies and RDV retreatment, especially in immunosuppressed patients with persistent replication after therapy.This work was financed by a Gilead Sciences grant (IN-ES-540-6089) and CIBER Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, España (CB21/13/00081). This work was financed by ad hoc patronage funds for research on COVID-19 from donations from citizens and organizations to the Hospital Clínic de Barcelona-Fundació Clínic per a la Recerca Biomèdica.S

Resultados de una encuesta sobre el soporte nutricional perioperatorio en la cirugía pancreática y biliar en España

Introduction: a survey on peri-operative nutritional support in pancreatic and biliary surgery among Spanish hospitals in 2007 showed that few surgical groups followed the 2006 ESPEN guidelines. Ten years later we sent a questionnaire to check the current situation. Methods: a questionnaire with 21 items sent to 38 centers, related to fasting time before and after surgery, nutritional screening use and type, time and type of peri-operative nutritional support, and number of procedures. Results: thirty-four institutions responded. The median number of pancreatic resections (head/total) was 29.5 (95% CI: 23.0-35; range, 5-68) (total, 1002); of surgeries for biliary malignancies (non-pancreatic), 9.8 (95% CI: 7.3-12.4; range, 2-30); and of main biliary resections for benign conditions, 10.4 (95% CI: 7.6-13.3; range, 2-33). Before surgery, only 41.2% of the sites used nutritional support (&lt; 50% used any nutritional screening procedure). The mean duration of preoperative fasting for solid foods was 9.3 h (range, 6-24 h); it was 6.6 h for liquids (range, 2-12). Following pancreatic surgery, 29.4% tried to use early oral feeding, but 88.2% of the surveyed teams used some nutritional support; 26.5% of respondents used TPN in 100% of cases. Different percentages of TPN and EN were used in the other centers. In malignant biliary surgery, 22.6% used TPN always, and EN in 19.3% of cases. Conclusions: TPN is the commonest nutrition approach after pancreatic head surgery. Only 29.4% of the units used early oral feeding, and 32.3% used EN; 22.6% used TPN regularly after surgery for malignant biliary tumours. The 2006 ESPEN guideline recommendations are not regularly followed 12 years after their publication in our country.Introducción: realizamos una encuesta sobre soporte nutricional perioperatorio en cirugía pancreática y biliar en hospitales españoles en 2007, que mostró que pocos grupos quirúrgicos seguían las guías de ESPEN 2006. Diez años después enviamos un cuestionario para comprobar la situación actual. Métodos: treinta y ocho centros recibieron un cuestionario con 21 preguntas sobre tiempo de ayunas antes y después de la cirugía, cribado nutricional, duración y tipo de soporte nutricional perioperatorio, y número de procedimientos. Resultados: respondieron 34 grupos. La mediana de pancreatectomías (cabeza/total) fue de 29,5 (IC 95 %: 23,0-35; rango, 5-68) (total, 1002), la de cirugías biliares malignas de 9,8 (IC 95 %: 7,3-12,4; rango, 2-30) y la de resecciones biliares por patología benigna de 10,4 (IC 95 %: 7,6-13,3; rango, 2-33). Solo el 41,2 % de los grupos utilizaban soporte nutricional antes de la cirugía (< 50 % habian efectuado un cribado nutricional). El tiempo medio de ayuno preoperatorio para sólidos fue de 9,3 h (rango, 6-24 h), y de 6,6 h para líquidos (rango, 2-12). Tras la pancreatectomía, el 29,4 % habían intentado administrar una dieta oral precoz, pero el 88,2 % de los grupos usaron algún tipo de soporte nutricional y el 26,5 % usaron NP en el 100 % de los casos. Los demás grupos usaron diferentes porcentajes de NP y NE en sus casos. En la cirugía biliar maligna, el 22,6 % utilizaron NP siempre y NE en el 19,3 % de los casos. Conclusiones: la NP es el soporte nutricional más utilizado tras la cirugía de cabeza pancreática. Solo el 29,4 % de las unidades usan nutrición oral precoz y el 32,3 % emplean la NE tras este tipo de cirugía. El 22,6 % de las instituciones usan NP habitualmente tras la cirugía de tumores biliares malignos. Las guías ESPEN 2006 no se siguen de forma habitual en nuestro país tras más de 10 años desde su publicación

Role of age and comorbidities in mortality of patients with infective endocarditis

[Purpose]: The aim of this study was to analyse the characteristics of patients with IE in three groups of age and to assess the ability of age and the Charlson Comorbidity Index (CCI) to predict mortality. [Methods]: Prospective cohort study of all patients with IE included in the GAMES Spanish database between 2008 and 2015.Patients were stratified into three age groups:<65 years,65 to 80 years,and ≥ 80 years.The area under the receiver-operating characteristic (AUROC) curve was calculated to quantify the diagnostic accuracy of the CCI to predict mortality risk. [Results]: A total of 3120 patients with IE (1327 < 65 years;1291 65-80 years;502 ≥ 80 years) were enrolled.Fever and heart failure were the most common presentations of IE, with no differences among age groups.Patients ≥80 years who underwent surgery were significantly lower compared with other age groups (14.3%,65 years; 20.5%,65-79 years; 31.3%,≥80 years). In-hospital mortality was lower in the <65-year group (20.3%,<65 years;30.1%,65-79 years;34.7%,≥80 years;p < 0.001) as well as 1-year mortality (3.2%, <65 years; 5.5%, 65-80 years;7.6%,≥80 years; p = 0.003).Independent predictors of mortality were age ≥ 80 years (hazard ratio [HR]:2.78;95% confidence interval [CI]:2.32–3.34), CCI ≥ 3 (HR:1.62; 95% CI:1.39–1.88),and non-performed surgery (HR:1.64;95% CI:11.16–1.58).When the three age groups were compared,the AUROC curve for CCI was significantly larger for patients aged <65 years(p < 0.001) for both in-hospital and 1-year mortality. [Conclusion]: There were no differences in the clinical presentation of IE between the groups. Age ≥ 80 years, high comorbidity (measured by CCI),and non-performance of surgery were independent predictors of mortality in patients with IE.CCI could help to identify those patients with IE and surgical indication who present a lower risk of in-hospital and 1-year mortality after surgery, especially in the <65-year group

Search for dark matter produced in association with bottom or top quarks in √s = 13 TeV pp collisions with the ATLAS detector

A search for weakly interacting massive particle dark matter produced in association with bottom or top quarks is presented. Final states containing third-generation quarks and miss- ing transverse momentum are considered. The analysis uses 36.1 fb−1 of proton–proton collision data recorded by the ATLAS experiment at √s = 13 TeV in 2015 and 2016. No significant excess of events above the estimated backgrounds is observed. The results are in- terpreted in the framework of simplified models of spin-0 dark-matter mediators. For colour- neutral spin-0 mediators produced in association with top quarks and decaying into a pair of dark-matter particles, mediator masses below 50 GeV are excluded assuming a dark-matter candidate mass of 1 GeV and unitary couplings. For scalar and pseudoscalar mediators produced in association with bottom quarks, the search sets limits on the production cross- section of 300 times the predicted rate for mediators with masses between 10 and 50 GeV and assuming a dark-matter mass of 1 GeV and unitary coupling. Constraints on colour- charged scalar simplified models are also presented. Assuming a dark-matter particle mass of 35 GeV, mediator particles with mass below 1.1 TeV are excluded for couplings yielding a dark-matter relic density consistent with measurements

Spatiotemporal Characteristics of the Largest HIV-1 CRF02_AG Outbreak in Spain: Evidence for Onward Transmissions

Background and Aim: The circulating recombinant form 02_AG (CRF02_AG) is the predominant clade among the human immunodeficiency virus type-1 (HIV-1) non-Bs with a prevalence of 5.97% (95% Confidence Interval-CI: 5.41–6.57%) across Spain. Our aim was to estimate the levels of regional clustering for CRF02_AG and the spatiotemporal characteristics of the largest CRF02_AG subepidemic in Spain.Methods: We studied 396 CRF02_AG sequences obtained from HIV-1 diagnosed patients during 2000–2014 from 10 autonomous communities of Spain. Phylogenetic analysis was performed on the 391 CRF02_AG sequences along with all globally sampled CRF02_AG sequences (N = 3,302) as references. Phylodynamic and phylogeographic analysis was performed to the largest CRF02_AG monophyletic cluster by a Bayesian method in BEAST v1.8.0 and by reconstructing ancestral states using the criterion of parsimony in Mesquite v3.4, respectively.Results: The HIV-1 CRF02_AG prevalence differed across Spanish autonomous communities we sampled from (p &lt; 0.001). Phylogenetic analysis revealed that 52.7% of the CRF02_AG sequences formed 56 monophyletic clusters, with a range of 2–79 sequences. The CRF02_AG regional dispersal differed across Spain (p = 0.003), as suggested by monophyletic clustering. For the largest monophyletic cluster (subepidemic) (N = 79), 49.4% of the clustered sequences originated from Madrid, while most sequences (51.9%) had been obtained from men having sex with men (MSM). Molecular clock analysis suggested that the origin (tMRCA) of the CRF02_AG subepidemic was in 2002 (median estimate; 95% Highest Posterior Density-HPD interval: 1999–2004). Additionally, we found significant clustering within the CRF02_AG subepidemic according to the ethnic origin.Conclusion: CRF02_AG has been introduced as a result of multiple introductions in Spain, following regional dispersal in several cases. We showed that CRF02_AG transmissions were mostly due to regional dispersal in Spain. The hot-spot for the largest CRF02_AG regional subepidemic in Spain was in Madrid associated with MSM transmission risk group. The existence of subepidemics suggest that several spillovers occurred from Madrid to other areas. CRF02_AG sequences from Hispanics were clustered in a separate subclade suggesting no linkage between the local and Hispanic subepidemics